Research Report On China’s Mecapegfilgrastim Market, 2021-2025
December 7, 2021 ⚊ 1 Min read ⚊ Views 206 ⚊ BUSINESS
According to Our company market research, the sales value of mecapegfilgrastim has grown significantly since its launch in China in 2018, reaching approximately CNY432 million (USD66.5 million) in 2020, with a CAGR of 1154% from 2018 to 2020. CRI expects that from 2021 to 2025, with the rising number of cancer cases in China, its Mecapegfilgrastim Market is still able to grow significantly. Similar drugs from other Chinese pharmaceutical companies are also expected to be marketed in the coming years.
Tags: life sciences market research report, mecapegfilgrasti, mecapegfilgrastim market
